BioCentury
ARTICLE | Top Story

Rhodia acquires ChiRex

July 24, 2000 7:00 AM UTC

RHA agreed to acquire CHRX for $31.25 per share in cash, valuing CHRX at $510 million. Rhodia is a specialty chemicals company, and CHRX is a provider of product development services and manufacturing...